Development of Czech National Stroke Guidelines
Language English Country Australia Media print
Document type Journal Article
PubMed
31283569
DOI
10.1097/xeb.0000000000000190
PII: 01787381-201906001-00004
Knihovny.cz E-resources
- MeSH
- Anticoagulants administration & dosage MeSH
- Stroke drug therapy prevention & control MeSH
- Atrial Fibrillation drug therapy MeSH
- Brain Ischemia prevention & control MeSH
- Humans MeSH
- Evidence-Based Medicine MeSH
- Guidelines as Topic MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
- Names of Substances
- Anticoagulants MeSH
Despite a significant transformation of ischaemic stroke management, it remains one of the leading causes of death, disability, functional impairment and cognitive deficits. With the advent of intravenous thrombolysis and mechanical thrombectomy, stroke is not an untreatable disease, mostly occurring in older people, any more. The most common cause of cardioembolic strokes is atrial fibrillation or flutter and atrial fibrillation is the most prevalent arrhythmia.The aim of this short communication is to describe the methodology of the Czech stroke guidelines development.High-quality 2017 Australian Stroke Foundation stroke guideline was considered for adaptation and a new guideline was developed and disseminated.
Department of Neurology Faculty of Medicine University Hospital Brno Masaryk University Brno
Department of Neurology Faculty of Medicine University Hospital Olomouc Palacky University Olomouc
Department of Neurology Faculty of Medicine University Hospital Ostrava Ostrava University Ostrava
Department of Neurology Regional Hospital Chomutov Chomutov
Department of Paediatrics T Bata Regional Hospital Zlin Czech Republic
Motol University Hospital Department of Neurology 2nd Faculty of Medicine Charles University Prague
References provided by Crossref.org